Clinical Trial Update: Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update for recombinant hyaluronidase in out-of-hospital use (EASI Access Trial) has completed; the study examined dehydration and mass casualty in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dehydration

Drugs mentioned

• Recombinant Hyaluronidase (rHuPH20) (hyaluronidase, recombinant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Mass Casualty Incident, Dehydration | Phase 3 | Status: COMPLETED